149 related articles for article (PubMed ID: 25402454)
1. Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation.
Bruch J; Xu H; De Andrade A; Höglinger G
PLoS One; 2014; 9(11):e113070. PubMed ID: 25402454
[TBL] [Abstract][Full Text] [Related]
2. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
3. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW
Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tau oligomeric seeds in progressive supranuclear palsy.
Gerson JE; Sengupta U; Lasagna-Reeves CA; Guerrero-Muñoz MJ; Troncoso J; Kayed R
Acta Neuropathol Commun; 2014 Jun; 2():73. PubMed ID: 24927818
[TBL] [Abstract][Full Text] [Related]
8. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.
Kadri F; Pacifici M; Wilk A; Parker-Struckhoff A; Del Valle L; Hauser KF; Knapp PE; Parsons C; Jeansonne D; Lassak A; Peruzzi F
J Biol Chem; 2015 Dec; 290(52):30931-46. PubMed ID: 26534959
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
Kowalska A; Jamrozik Z; Kwieciński H
Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
[TBL] [Abstract][Full Text] [Related]
11. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
[TBL] [Abstract][Full Text] [Related]
12. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
13. Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
Luk C; Giovannoni G; Williams DR; Lees AJ; de Silva R
J Neurosci Methods; 2009 May; 180(1):34-42. PubMed ID: 19427527
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.
Yin X; Jiang X; Wang J; Qian S; Liu F; Qian W
J Alzheimers Dis; 2018; 61(2):561-570. PubMed ID: 29226865
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.
Chen KL; Yuan RY; Hu CJ; Hsu CY
Neurobiol Dis; 2010 Nov; 40(2):378-85. PubMed ID: 20615469
[TBL] [Abstract][Full Text] [Related]
16. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
[TBL] [Abstract][Full Text] [Related]
18. Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration.
Levy SF; Leboeuf AC; Massie MR; Jordan MA; Wilson L; Feinstein SC
J Biol Chem; 2005 Apr; 280(14):13520-8. PubMed ID: 15671021
[TBL] [Abstract][Full Text] [Related]
19. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation.
Richter-Landsberg C; Gorath M
J Neurosci Res; 1999 May; 56(3):259-70. PubMed ID: 10336255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
